Moderate to Severe Asthma: Journal Articles

• Effectiveness of mRNA Vaccines Among Children Aged 3-5 Years Do the mRNA COVID-19 vaccines effectively provide protection against symptomatic infection among children in this age group?
  Morbidity & Mortality Weekly Report, May 05, 2023
• Peripheral Blood Eosinophilia and Asthma Severity What could blood eosinophil counts tell us about disease severity in asthma?
  BMC Pulmonary Medicine, May 03, 2023
• Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants This study confirms that a bivalent mRNA booster dose provides additional protection against symptomatic XBB/XBB.1.5 infection for at least 3 months after vaccination.
  Morbidity & Mortality Weekly Report, April 17, 2023
• The Influence of COVID-19 Disease on Asthma What have we learned about the impacts of the COVID-19 virus infection among people with asthma?
  BMC Pulmonary Medicine, March 24, 2023
• Experience of Super-Responders to Biologics in Severe Asthma A new study provides insight into the profound impact of biologic treatment for severe asthma among super responders -- from the patient's perspective.
  BMC Pulmonary Medicine, January 13, 2023
• Astegolimab or Efmarodocokin Alfa in Severe COVID-19 Are these drugs effective in the treatment of hospitalized patients with severe COVID-19 pneumonia?
  Critical Care Medicine, January 11, 2023
• Infertility, Pregnancy Loss and ART in Women With Asthma Does asthma in women impact their risk of infertility, pregnancy loss or need for assisted reproduction?
  Human Reproduction, December 30, 2022
• Real-World Effectiveness of Omalizumab for Severe Asthma Findings from a real-world study support the benefits of omalizumab as a treatment option for both pediatric and adult patients with severe allergic asthma.
  BMC Pulmonary Medicine, December 30, 2022
• Is Immunotherapy Safe For Treatment of Severe Asthma Allergen immunotherapy has been established as an effective treatment for mild and moderate asthmatic patients. Could those with severe asthma also benefit from this therapy?
  Current Opinion in Allergy and Clinical Immunology, November 18, 2022
• Dupilumab in Mild to Moderate Asthma Comorbid With CRSwNP Is dupilumab an effective treatment option for asthma patients with chronic sinusitis with nasal polyps? A new study examines the real-life effects.
  BMC Pulmonary Medicine, August 12, 2022
• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• COVID-19 and Pediatric Asthma: Friend or Foe? What do we currently know about the interplay between COVID-19 and asthma in children?
  Current Opinion in Allergy and Clinical Immunology, March 17, 2022
• Cost-Utility of Triple vs Dual Inhaler Therapy in Asthma Which of these treatment options for moderate to severe asthma is most cost-effective?
  BMC Pulmonary Medicine, February 10, 2022
• Severe Refractory Asthma Treated With Benralizumab Is benralizumab an effective alternative for severe eosinophilic asthma patients who did not respond to other biologic treatments?
  BMC Pulmonary Medicine, January 27, 2022
• Optimizing Inhalation Therapy in COPD and Asthma Patients Which strategies may help COPD or asthma patients achieve optimal inhalation flow rates?
  BMC Pulmonary Medicine, October 28, 2021
• The Effect of Curcumin in Moderate to Severe Asthmatics Are curcumin supplements beneficial in the management of patients with moderate to severe asthma?
  BMC Pulmonary Medicine, October 06, 2021
• Is Asthma a Risk Factor for COVID-19 Worse Outcomes? Evidence suggests that asthma patients may not have a higher risk for COVID-19 or worse outcomes, but optimizing asthma management during the pandemic is key.
  Current Opinion in Allergy and Clinical Immunology, May 17, 2021
• Spontaneous Resolution of Atopic Dermatitis With Benralizumab This patient experienced spontaneous resolution of atopic dermatitis while participating in a trial of benralizumab for severe asthma, highlighting the potential shared mechanisms of these conditions.
  Journal of Medical Case Reports, May 13, 2021
• Asthma, SARS-CoV-2 and COVID-19 What have we learned about the interaction between asthma and COVID-19? Might asthma medications have an impact on outcomes?
  Current Opinion in Allergy and Clinical Immunology, March 18, 2021
• Advances in Allergen Immunotherapy for Asthma What have we learned about the benefits of allergen immunotherapy as a therapeutic option for asthma?
  Current Opinion in Allergy and Clinical Immunology, November 12, 2020